Life Science & Biotech

Life sciences leader juggles faith, science and businessRestricted Content

November 3, 2012
J.K. Wall
BioCrossroads CEO David Johnson sees little conflict as he balances all three in promoting and investing in Indiana life sciences firms
More

Purdue researcher harbors high hopes for new ventureRestricted Content

November 3, 2012
Scott Olson
Pete Kissinger hopes Phlebotics will follow in the footsteps of another of his creations, Bioanalytical Systems Inc.
More

Lilly to spend $140M on new insulin cartridge plant

November 1, 2012
J.K. Wall
About 100 workers will staff the new plant, which will be constructed by spring 2014 and ready for operations in 2015. But only “some” of that number will be new hires.
More

Lilly plans expansion of local insulin plant

October 30, 2012
J.K. Wall
The Indianapolis-based drugmaker plans to expand its local insulin plants to make insulin cartridges to meet what it describes as growing demand in the United States.
More

Outlook gloomy for device investments

October 29, 2012
J.K. Wall
The amount of venture capital invested in medical-device and equipment companies nationally has declined each quarter this year, reaching levels not seen since 2004, according to data released Oct. 19 by the National Venture Capital Association and PricewaterhouseCoopers.
More

Profit falls at Dow AgroSciences even as sales rise

October 24, 2012
J.K. Wall
Strong demand from farmers boosted sales by 8 percent at Dow AgroSciences LLC in the third quarter, but continued investments in new technologies slashed profits by 16 percent.
More

Lilly CEO calls for life sciences research institute

October 23, 2012
J.K. Wall
Eli Lilly CEO John Lechleiter on Tuesday called for creation of a "world-class" research institute in Indianapolis to bring together scientists from universities and corporations to develop new medical therapies and companies.
More

Roche continues to restructure diabetes unit

October 22, 2012
J.K. Wall
Roche officials said last week that price competition and lower reimbursement rates are forcing it to make an unspecified number of cuts in its U.S. sales force and at its research and development hubs in Indianapolis and Germany.
More

DANZ: Indianapolis tech community should build momentumRestricted Content

October 20, 2012
Kristine Danz / Special to IBJ
More money, mentoring would add fuel to lively industry.
More

Indianapolis tech firms, hospitals discover mutual needRestricted Content

October 20, 2012
Chris O'Malley
An initiative is matching tech entrepreneurs with hospital officials in the hope of solving health care problems.
More

Lilly stomach-cancer drug helps survival, study finds

October 15, 2012
Bloomberg News
Eli Lilly and Co. shares rose nearly 5 percent Monday morning after it said a study found that its experimental stomach-cancer drug helped patients with advanced disease live longer.
More

Evans to lead AIT again as CEO leaves company

October 15, 2012
 IBJ Staff
Ron Thieme, who took over as president and CEO of AIT Laboratories during a management shakeup earlier this year, is leaving the company, the Indianapolis-based firm announced Monday morning.
More

Lilly counting on diabetes products to challenge larger rivals

October 8, 2012
Bloomberg News
Eli Lilly and Co. is betting on a “broad” range of diabetes products including pills, insulins and a once-a-week treatment to take on bigger competitors, said Enrique Conterno, president of Lilly Diabetes.
More

IBJ Health Care Power Breakfast - transcript

October 2, 2012
Indianapolis Business Journal convened a panel of experts at its Health Care & Benefits Power Breakfast on Sept. 28 to talk about industry issues including Medicaid, on-site health clinics and narrow networks. Panelists included Robert J. Brody, president and CEO of Franciscan St. Francis Health; Michael N. Heaton, partner, Katz Sapper & Miller; Dr. Gregory N. Larkin, commissioner, Indiana State Department of Health; Vicki F. Perry, president, CEO, Advantage Health Solutions Inc.; Dr. Ram Yeleti, president, Community Physician Network. The following is the unedited transcript of the discussion.
More

Dow Agro awarded $5.3M in patent-infringement case

October 2, 2012
The unsuccessful lawsuit filed by a subsidiary of Belgium-based Bayer Bioscience claimed that insect-resistant corn products from affiliates of Dow AgroSciences violated two of its patents.
More

Vegetable growers, Dow settle dispute over new herbicide

September 11, 2012
J.K. Wall
A coalition of vegetable growers and food producers led by Indiana-based Red Gold Inc. will ease off their opposition to a new herbicide developed by Indianapolis-based Dow AgroSciences LLC.
More

$100M IU neuroscience center set to open

August 24, 2012
Associated Press
A $100 million neuroscience center Indiana University officials say will offer a "one stop shop" for patients recovering from head and spinal injuries, strokes and other medical conditions is days away from opening its doors in Indianapolis.
More

Life sciences firm Hologic closing 200-worker Zionsville facility

August 15, 2012
J.K. Wall
Massachusetts-based Hologic Inc., the company that bought Suros Surgical Systems Inc., will phase out its facility in Zionsville, bringing an end to 200 local jobs.
More

Indiana life sciences companies rethink innovationRestricted Content

July 28, 2012
J.K. Wall
Research and development comes under pressure in an age of austerity.
More

Indiana Blood Center tapping new vein of revenueRestricted Content

July 28, 2012
Mason King
Group sees role in cellular therapy as growth area with profit margins higher than core business.
More

Life Sciences Power Breakfast - transcript

July 28, 2012
Life sciences leaders discuss topics ranging from accomplishments to initial public offerings and the nature of innovation at the July 25 event.
More

Cook Medical shelves Midwest expansion plans

July 27, 2012
J.K. Wall
Life Sciences Cook Yonkman watch videoCook Medical Inc. had been planning to open five new manufacturing plants over the next five years in small communities around the Midwest, including Indiana, but has shelved those plans because of the hit it will take from a new U.S. tax on medical devices.
More

Dow Agro sales surge to record in second quarter

July 26, 2012
The Indianapolis-based division of Dow Chemical Co. posted record second quarter sales of $1.7 billion, up 12 percent from the year-ago period, due to a small increase in prices and the introduction of new products.
More

Bioanalytical taps accountant for turnaround

July 9, 2012
J.K. Wall
With spending running well ahead of revenue, West Lafayette-based Bioanalytical Systems Inc. ousts its CEO in favor of its CFO.
More

Life sciences hold up in recession

June 25, 2012
J.K. Wall
A new report shows Indiana’s life sciences companies performed better than their peers around the country—and far better than the rest of Indiana’s private sector—during the early phases of the economic downturn.
More
Page  << 1 2 3 4 5 6 7 8 9 10 >> pager
Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
ADVERTISEMENT